LifeStance Health (LFST) Common Equity (2020 - 2026)

LifeStance Health (LFST) has reported Common Equity for 7 consecutive years, with $1.5 billion the latest figure, recorded in Q1 2026.

• In Q1 2026, Common Equity rose 1.39% year-over-year to $1.5 billion; the TTM figure through Mar 2026 stood at $1.5 billion (up 1.39% YoY), while the FY2025 annual figure was $1.5 billion, up 5.17% from the prior year.
• Common Equity declined to $1.5 billion in Q1 2026 per LFST's latest filing, from $1.5 billion in the prior quarter.
• Across five years, Common Equity topped out at $1.5 billion in Q1 2022 and bottomed at $1.4 billion in Q4 2023.
• Historically, Common Equity has averaged $1.5 billion across 5 years, with a median of $1.5 billion in 2026.
• Annual changes were most pronounced in 2022 — Common Equity jumped 61.69% — and 2023, when it dropped 5.91%.
• LifeStance Health's Common Equity stood at $1.5 billion in 2022, then slipped by 5.91% to $1.4 billion in 2023, then gained by 1.21% to $1.4 billion in 2024, then gained by 5.17% to $1.5 billion in 2025, then fell by 2.87% to $1.5 billion in 2026.
• Business Quant data shows LFST's Common Equity at $1.5 billion in Q1 2026, $1.5 billion in Q4 2025, and $1.5 billion in Q3 2025.